Eric C Seaberg1, Mallory D Witt2, Lisa P Jacobson1, Roger Detels3, Charles R Rinaldo4, Joseph B Margolick5, Stephen Young6, John P Phair7, Chloe L Thio8. 1. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 2. David Geffen School of Medicine, University of California-Los Angeles Los Angeles Biomedical Research Institute at Harbor University of California-Los Angeles, Torrance. 3. Department of Epidemiology, University of California-Los Angeles, School of Public Health, California. 4. Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania. 5. Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 6. Department of Pathology, University of New Mexico HSC, Albuquerque. 7. Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 8. Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Abstract
BACKGROUND: The probability of spontaneous hepatitis C virus (HCV) clearance ranges from 11% to 49%. Our previous cross-sectional study suggests that mode of acquisition explains some of this heterogeneity. We performed this prospective study to determine factors associated with spontaneous HCV clearance among men who have sex with men (MSM). METHODS: A mixture-cure model was used to evaluate the probability of spontaneous HCV clearance among 101 MSM in the Multicenter AIDS Cohort Study with acute HCV infection between 1984 and 2012. RESULTS: Spontaneous HCV clearance occurred in 46% of MSM (49% in non-injection drug users [IDUs] and 23% in IDUs). In the multivariable analysis, age <30 years (clearance ratio [CR] = 2.43; 95% confidence interval [CI], 1.53-3.87) and being human immunodeficiency virus (HIV) uninfected (CR = 2.97; 95% CI, 1.98-4.46) were independently associated with spontaneous clearance. Among men aged ≥30 years, being HIV uninfected, not having unprotected anal intercourse, older age, and being on highly active antiretroviral therapy were independently associated with higher clearance. The interferon lambda rs12979860 single nucleotide polymorphism (SNP) was not associated with spontaneous clearance among the 88 MSM who were not active IDUs (CR = 0.74; 95% CI, .46-1.21 for CC vs CT/TT genotype). CONCLUSIONS: The high probability of spontaneous HCV clearance together with the lack of an association between the rs12979860 SNP and spontaneous clearance among MSM who do not use injection drugs suggests that the immune mechanisms involved with a successful response to acute HCV differ by mode of virus acquisition. Understanding potential mechanistic differences could be important for HCV vaccine development.
BACKGROUND: The probability of spontaneous hepatitis C virus (HCV) clearance ranges from 11% to 49%. Our previous cross-sectional study suggests that mode of acquisition explains some of this heterogeneity. We performed this prospective study to determine factors associated with spontaneous HCV clearance among men who have sex with men (MSM). METHODS: A mixture-cure model was used to evaluate the probability of spontaneous HCV clearance among 101 MSM in the Multicenter AIDS Cohort Study with acute HCV infection between 1984 and 2012. RESULTS: Spontaneous HCV clearance occurred in 46% of MSM (49% in non-injection drug users [IDUs] and 23% in IDUs). In the multivariable analysis, age <30 years (clearance ratio [CR] = 2.43; 95% confidence interval [CI], 1.53-3.87) and being human immunodeficiency virus (HIV) uninfected (CR = 2.97; 95% CI, 1.98-4.46) were independently associated with spontaneous clearance. Among men aged ≥30 years, being HIV uninfected, not having unprotected anal intercourse, older age, and being on highly active antiretroviral therapy were independently associated with higher clearance. The interferon lambda rs12979860 single nucleotide polymorphism (SNP) was not associated with spontaneous clearance among the 88 MSM who were not active IDUs (CR = 0.74; 95% CI, .46-1.21 for CC vs CT/TT genotype). CONCLUSIONS: The high probability of spontaneous HCV clearance together with the lack of an association between the rs12979860 SNP and spontaneous clearance among MSM who do not use injection drugs suggests that the immune mechanisms involved with a successful response to acute HCV differ by mode of virus acquisition. Understanding potential mechanistic differences could be important for HCV vaccine development.
Authors: Anthony J Silvestre; John B Hylton; Lisette M Johnson; Carmoncelia Houston; Mallory Witt; Lisa Jacobson; David Ostrow Journal: Am J Public Health Date: 2006-05-02 Impact factor: 9.308
Authors: Mingdong Zhang; Philip S Rosenberg; Deborah L Brown; Liliana Preiss; Barbara A Konkle; M Elaine Eyster; James J Goedert Journal: Blood Date: 2005-10-04 Impact factor: 22.113
Authors: D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov Journal: JAMA Date: 2000-07-26 Impact factor: 56.272
Authors: Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter Journal: Ann Intern Med Date: 2006-05-16 Impact factor: 25.391
Authors: Arthur Y Kim; Julian Schulze zur Wiesch; Thomas Kuntzen; Joerg Timm; Daniel E Kaufmann; Jared E Duncan; Andrea M Jones; Alysse G Wurcel; Benjamin T Davis; Rajesh T Gandhi; Gregory K Robbins; Todd M Allen; Raymond T Chung; Georg M Lauer; Bruce D Walker Journal: PLoS Med Date: 2006-12 Impact factor: 11.069
Authors: Mattias Mandorfer; Philipp Schwabl; Sebastian Steiner; Thomas Reiberger; Markus Peck-Radosavljevic Journal: Hepatol Int Date: 2016-01-12 Impact factor: 6.047
Authors: Hannah Fraser; Christinah Mukandavire; Natasha K Martin; Matthew Hickman; Myron S Cohen; William C Miller; Peter Vickerman Journal: Int J Epidemiol Date: 2017-04-01 Impact factor: 7.196
Authors: N Durier; E Yunihastuti; K Ruxrungtham; N V Kinh; A Kamarulzaman; D Boettiger; A Widhani; A Avihingsanon; B V Huy; S F B Syed Omar; A Sanityoso; S Chittmittrapap; N T H Dung; V Pillai; T Suwan-Ampai; M Law; A H Sohn; G Matthews Journal: J Viral Hepat Date: 2016-12-05 Impact factor: 3.728
Authors: David Chromy; Mattias Mandorfer; Theresa Bucsics; Philipp Schwabl; Bernhard Scheiner; Caroline Schmidbauer; Maximilian Christopher Aichelburg; Peter Ferenci; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger Journal: United European Gastroenterol J Date: 2019-03-06 Impact factor: 4.623
Authors: Candelaria Vergara; Chloe L Thio; Eric Johnson; Alex H Kral; Thomas R O'Brien; James J Goedert; Alessandra Mangia; Valeria Piazzolla; Shruti H Mehta; Gregory D Kirk; Arthur Y Kim; Georg M Lauer; Raymond T Chung; Andrea L Cox; Marion G Peters; Salim I Khakoo; Laurent Alric; Matthew E Cramp; Sharyne M Donfield; Brian R Edlin; Michael P Busch; Graeme Alexander; Hugo R Rosen; Edward L Murphy; Rachel Latanich; Genevieve L Wojcik; Margaret A Taub; Ana Valencia; David L Thomas; Priya Duggal Journal: Gastroenterology Date: 2018-12-26 Impact factor: 22.682
Authors: Yun-Chi Chen; Kjell J Wiberg; Yu-Hsiang Hsieh; Arun Bansal; Philipe Bolzan; Janelle A Guy; Erastus N Maina; Andrea L Cox; Chloe L Thio Journal: Open Forum Infect Dis Date: 2016-06-29 Impact factor: 3.835
Authors: Mark Hull; Stephen Shafran; Alex Wong; Alice Tseng; Pierre Giguère; Lisa Barrett; Shariq Haider; Brian Conway; Marina Klein; Curtis Cooper Journal: Can J Infect Dis Med Microbiol Date: 2016-07-04 Impact factor: 2.471
Authors: Mark H Kuniholm; Edgar Ong; Boris M Hogema; Marco Koppelman; Kathryn Anastos; Marion G Peters; Eric C Seaberg; Yue Chen; Kenrad E Nelson; Jeffrey M Linnen Journal: Hepatology Date: 2016-01-16 Impact factor: 17.425